Report #2888133

Received Jun 15, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 65 yrs
State: —
Recovered: Not recovered
Vaccinated: Feb 20, 2026
Onset: Feb 20, 2026
Days to onset: 0
Hospital days: —

Vaccines (3)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RSV	RSV (AREXVY)	GLAXOSMITHKLINE BIOLOGICALS	1	92b39	IM / LA
RSV	RSV (AREXVY)	GLAXOSMITHKLINE BIOLOGICALS	UNK	92B39	LA
RSV	RSV (AREXVY)	GLAXOSMITHKLINE BIOLOGICALS	UNK	92B39	—

Symptoms (8)

HeadacheHypoaesthesiaImpaired work abilityInjection site painJoint injuryPain in extremitySomnolenceMalaise

Symptom narrative

Not feeling good after vaccine; This non-serious case was reported by a consumer via call center representative and described the occurrence of feeling abnormal in a 65-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) suspension for injection (batch number 92B39) for prophylaxis. On 20-FEB-2026, the patient received Arexvy. On 20-FEB-2026, less than a day after receiving Arexvy, the patient experienced feeling abnormal (Verbatim: Not feeling good after vaccine). The outcome of the feeling abnormal was not resolved. It was unknown if the reporter considered the feeling abnormal to be related to Arexvy. Additional Information: GSK Receipt Date:10-JUN-2026 The reporter called and reported that they received Arexvy and since that, they had not feeling good and it change whole life.